Effects of New Antiepileptic Drugs on Homocysteine in Epileptic Patients: A Systematic Review and Meta‐Analysis
Journal of Clinical Pharmacy and Therapeutics · 2023-01 · 2023 (1)
DOI: 10.1155/2023/5878004 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 21.04.2023. Verfasst von Danyi Zheng und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shaoxing Bureau of Science and Technology.
Abstract (Originalsprache)
Background
Previous studies have reported inconsistent findings regarding the association between elevated plasma homocysteine (Hcy) levels and new antiepileptic drugs (AEDs). In this meta‐analysis, we aimed to assess the effects of new AEDs on Hcy.
Methods
PubMed, Embase, Cochrane, and Web of Science databases were searched from inception to June 2022 for articles that focused on the effects of new AEDs on Hcy. A meta‐analysis was performed using Stata 16.0 software. The results were presented as the mean difference (MD) and corresponding to 95% confidence intervals (CIs) comparing epileptic patients with new AEDs to the control subjects.
Results
A total of 11 studies were included in the meta‐analysis. Hcy was markedly increased in the new AEDs group compared with the control group (MD = 2.220, 95% CI: 0.596–3.844, P = 0.007), with a high degree of heterogeneity ( I 2 = 99.5%). In the drugs subgroup, the oxcarbazepine (OXC) (MD = 2.30, 95% CI: −1.11–5.72, P = 0.187) and lamotrigine (LTG) (MD = 1.14, 95% CI: −0.209–2.482, P < 0.001) groups had no significant differences when compared with the control group. The levetiracetam (LEV) (MD = 1.81, 95% CI: 1.03–2.18, P < 0.001) and topiramate (TPM) (MD = 6.922, 95% CI: 0.788–13.055, P = 0.027) groups were significantly higher than the control group.
Conclusions
The new AEDs, especially TPM and LEV, may increase the plasma of Hcy. The role of Hcy in patients with epilepsy who are given TPM and LEV should not be ignored in clinical situations. Patients with epilepsy who also have a high‐risk vascular profile are recommended to use OXC and LTG.
Förderung
- Shaoxing Bureau of Science and Technology
Zitieren
APA
Zheng, D., Bao, Y., Gu, J., Lv, T., & Yang, Y. (2023). Effects of New Antiepileptic Drugs on Homocysteine in Epileptic Patients: A Systematic Review and Meta‐Analysis. Journal of Clinical Pharmacy and Therapeutics, 2023(1). https://doi.org/10.1155/2023/5878004
Vancouver
Zheng D, Bao Y, Gu J, Lv T, Yang Y. Effects of New Antiepileptic Drugs on Homocysteine in Epileptic Patients: A Systematic Review and Meta‐Analysis. Journal of Clinical Pharmacy and Therapeutics. 2023;2023(1). doi:10.1155/2023/5878004
BibTeX
@article{Zheng2023,
author = {Zheng, Danyi and Bao, Yaya and Gu, Jiayi and Lv, Tian and Yang, Yue},
title = {Effects of New Antiepileptic Drugs on Homocysteine in Epileptic Patients: A Systematic Review and Meta‐Analysis},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2023},
volume = {2023},
number = {1},
doi = {10.1155/2023/5878004}
}
EUVIMED